- gsearch

- gsearch

CDC Stacks Public Health Publications

Search Results

Narrow Results:
Publication Year
Medical Subject
Personal Author
  • Li, Han (9)
Corporate Author
Place as Subject
Resource Type General
  • Lethal Factor Toxemia and AntiProtective Antigen Antibody Activity in Naturally Acquired Cutaneous Anthrax
    Lethal Factor Toxemia and Anti-Protective Antigen Antibody Activity in Naturally Acquired Cutaneous Anthrax
    :
    :
  • Effect of reduced dose schedules and intramuscular injection of anthrax vaccine adsorbed on immunological response and safety profile A randomized trial
    Effect of reduced dose schedules and intramuscular injection of anthrax vaccine adsorbed on immunological response and safety profile: A randomized trial☆☆
    :
    :
  • Comparison of Estimated SARSCoV2 Seroprevalence through Commercial Laboratory Residual Sera Testing and a Community Survey
    Comparison of Estimated SARS-CoV-2 Seroprevalence through Commercial Laboratory Residual Sera Testing and a Community Survey
    :
    :
  • Anthrax ToxinExpressing Bacillus cereus Isolated from an AnthraxLike Eschar
    Anthrax Toxin-Expressing Bacillus cereus Isolated from an Anthrax-Like Eschar
    :
    :
  • Specific Sensitive and Quantitative EnzymeLinked Immunosorbent Assay for Human Immunoglobulin G Antibodies to Anthrax Toxin Protective Antigen
    Specific, Sensitive, and Quantitative Enzyme-Linked Immunosorbent Assay for Human Immunoglobulin G Antibodies to Anthrax Toxin Protective Antigen
    :
    :
  • Estimated SARSCoV2 Seroprevalence Among Persons Aged 18 Years  Mississippi MaySeptember 2020
    Estimated SARS-CoV-2 Seroprevalence Among Persons Aged <18 Years — Mississippi, May–September 2020
    :
    No Description
  • Decline in SARSCoV2 Antibodies After Mild Infection Among Frontline Health Care Personnel in a Multistate Hospital Network  12 States AprilAugust 2020
    Decline in SARS-CoV-2 Antibodies After Mild Infection Among Frontline Health Care Personnel in a Multistate Hospital Network — 12 States, April–August 2020
    :
    :
  • Seroprevalence of SARSCoV2 Among Frontline Health Care Personnel in a Multistate Hospital Network  13 Academic Medical Centers AprilJune 2020
    Seroprevalence of SARS-CoV-2 Among Frontline Health Care Personnel in a Multistate Hospital Network — 13 Academic Medical Centers, April–June 2020
    :
    :
  • Seroprevalence of SARSCoV2 Among Frontline Health Care Personnel in a Multistate Hospital Network  13 Academic Medical Centers AprilJune 2020
    Seroprevalence of SARS-CoV-2 Among Frontline Health Care Personnel in a Multistate Hospital Network — 13 Academic Medical Centers, April–June 2020
    :
    :